HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Panomwat Amornphimoltham Selected Research

MTOR Inhibitors

1/20194E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
10/2016mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
11/2011Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.
1/2009Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.
12/2008Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Panomwat Amornphimoltham Research Topics

Disease

20Neoplasms (Cancer)
01/2019 - 06/2003
19Squamous Cell Carcinoma of Head and Neck
05/2022 - 06/2003
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 09/2007
4Carcinoma (Carcinomatosis)
01/2019 - 08/2004
4Neoplasm Metastasis (Metastasis)
03/2015 - 09/2011
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2009 - 06/2003
3Carcinogenesis
01/2009 - 11/2004
2Hyperplasia
10/2016 - 12/2004
1Sepsis (Septicemia)
01/2019
1Rupture
01/2019
1Bone Resorption
01/2018
1Hypersensitivity (Allergy)
04/2015
1Anaphylaxis (Anaphylactic Shock)
04/2015
1Asthma (Bronchial Asthma)
04/2015
1Whooping Cough (Pertussis)
03/2015
1Mouth Neoplasms (Oral Cancer)
03/2013
1Breast Neoplasms (Breast Cancer)
09/2011
1Neuroinflammatory Diseases
08/2011
1Hypoxia (Hypoxemia)
02/2008
1Papilloma (Papillomatosis)
12/2004
1Nasopharyngeal Carcinoma
08/2004
1Lymphoma (Lymphomas)
08/2004

Drug/Important Bio-Agent (IBA)

8Sirolimus (Rapamycin)FDA Link
10/2016 - 11/2005
5MTOR InhibitorsIBA
01/2019 - 12/2008
5TOR Serine-Threonine KinasesIBA
01/2009 - 11/2005
3Biomarkers (Surrogate Marker)IBA
01/2019 - 11/2004
3Phosphotransferases (Kinase)IBA
02/2014 - 08/2004
3Conditioned Culture MediaIBA
06/2012 - 06/2003
3Transforming Growth Factor beta (TGF-beta)IBA
04/2009 - 08/2004
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2019
2Doxycycline (Periostat)FDA LinkGeneric
10/2016 - 12/2004
2CarcinogensIBA
10/2016 - 12/2008
2LigandsIBA
03/2015 - 09/2011
2ChemokinesIBA
03/2015 - 09/2011
2CollagenIBA
03/2013 - 06/2012
2Matrix Metalloproteinases (MMPs)IBA
06/2012 - 02/2009
2beta CateninIBA
04/2009 - 08/2004
2CytokinesIBA
02/2009 - 06/2003
2Interleukin-6 (Interleukin 6)IBA
02/2009 - 06/2003
2ErbB Receptors (EGF Receptor)IBA
09/2007 - 06/2003
2Complementary DNA (cDNA)IBA
11/2004 - 08/2004
1HistatinsIBA
05/2022
1Immune Checkpoint InhibitorsIBA
12/2019
1NADH DehydrogenaseIBA
01/2019
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2019
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2019
1AMP-Activated Protein KinasesIBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1RANK LigandIBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Notch ReceptorsIBA
01/2018
1Caspase 3 (Caspase-3)IBA
03/2016
1trametinibIBA
03/2016
1Histamine (Histamine Dihydrochloride)FDA Link
04/2015
1Mechanistic Target of Rapamycin Complex 2IBA
03/2015
1Mechanistic Target of Rapamycin Complex 1IBA
03/2015
1Chemokine ReceptorsIBA
03/2015
1SB 203580IBA
02/2014
1MitogensIBA
02/2014
1p38 Mitogen-Activated Protein KinasesIBA
02/2014
1Actins (F Actin)IBA
03/2013
1Monomeric GTP-Binding ProteinsIBA
03/2013
1IntegrinsIBA
06/2012
1EverolimusFDA Link
11/2011
1GTP-Binding Proteins (G-Protein)IBA
09/2011
1Chemokine CXCL12IBA
09/2011
1GuanosineIBA
09/2011
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2011
1CXC ChemokinesIBA
09/2011
1LipopolysaccharidesIBA
08/2011
1Cyclooxygenase 1IBA
08/2011
1Collagen Type I (Type I Collagen)IBA
02/2009
1Messenger RNA (mRNA)IBA
02/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2008
1AntibodiesIBA
09/2007
1Keratins (Keratin)IBA
05/2006
1Keratin-5 (Keratin 5)IBA
05/2006
1DNA (Deoxyribonucleic Acid)IBA
11/2005
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2005
1Carrier Proteins (Binding Protein)IBA
11/2005
1Peptide Initiation Factors (Initiation Factor)IBA
11/2005
1CyclinsIBA
11/2004
1Integrin beta4IBA
08/2004
1Carcinoembryonic AntigenIBA
08/2004
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
08/2004
1Cyclin D2IBA
08/2004
1Cyclin B1IBA
08/2004
1Cell Adhesion MoleculesIBA
08/2004
1RNA (Ribonucleic Acid)IBA
08/2004
1calpastatinIBA
08/2004
1Secretory Leukocyte Peptidase InhibitorIBA
08/2004
1Matrix Metalloproteinase 11IBA
08/2004
1Keratin-7 (Cytokeratin 7)IBA
08/2004

Therapy/Procedure

4Therapeutics
01/2017 - 09/2007
1Immunotherapy
12/2019
1Punctures
01/2019
1Chemoprevention
01/2009
1Lasers (Laser)
08/2004